帮助 本站公告
您现在所在的位置:网站首页 > 知识中心 > 文献详情
文献详细Journal detailed

不同剂量阿托伐他汀对缺血性心肌病患者血清8-OHdG水平的影响
Effects of Different Doses of Atorvastatin on 8-OHdG Levels in Serum of Patients with Ischemic Cardiomyopathy

作  者: (靳钰); (丁世芳); (陈志楠); (蒋桔泉); (姜其钧);

机构地区: 解放军武汉总医院心血管内科,湖北武汉430070

出  处: 《华南国防医学杂志》 2017年第7期471-473,491,共4页

摘  要: 目的比较20 mg与40 mg阿托伐他汀对缺血性心肌病(ischemic cardiomyopathy,ICM)患者血清8-羟基脱氧鸟嘌呤(8-hydroxy deoxyguanosine,8-OHdG)水平的影响。方法按随机数字表法将246例患者分为两组:阿托伐他汀20 mg/d治疗组(20 mg治疗组,n=124)和40 mg/d治疗组(40 mg治疗组,n=122)。1年随访期。结果患者均完成1年随访,在随访期内两组药物应用方面差异无显著性差异(P>0.05),两组横纹肌溶解、药物性肝炎及其他不良反应比较差异无统计学意义(P>0.05)。组内比较:两组患者总胆固醇(total cholesterol,TC)、低密度脂蛋白胆固醇(low-density lipoprotein cholesterol,LDL-C)均较治疗前明显降低(P<0.05);治疗后,40 mg治疗组超敏-C反应蛋白(high-sensitive Creactive protein,hs-CRP)、脑利钠肽(brain natriuretic peptide,BNP)和8-Ohd G水平明显低于治疗前,差异具有统计学意义(P<0.05)。组间比较:治疗后40 mg治疗组的hs-CRP、BNP和8-OHdG较20 mg治疗组明显降低,差异有统计学意义(P<0.05)。结论阿托伐他汀的抗氧化作用与剂量存在关系,40 mg阿托伐他汀较20 mg阿托伐他汀的抗氧化作用明显。 Objective To investigate the differences between 20 mg and 40 mg atorvastatin in patients with ische- mic cardiomyopathy (ICM) on 8-hydroxy deoxyguanosine (8-OHdG). Methods A total of 246 hospitalized ICM patients were divided into 20 mg/d (20 mg treatment group, n = 124) and 40 mg/d (40 mg treatment group, n = 122) atorvastatin treatment groups in accordance with the random number. The adverse drug reactions were recorded during a one-year fol- low-up. Results All ICM patients were followed up for 1 year. No significant differences were found in the drug use, drug-induced liver disease, rhabdomyolysis and other adverse drug reactions between two groups (P〉0. 05). Intra-group comparison showed the total cholesterol (TC) and low-density lipoprotein cholesterin (LDL-C) decreased (P〈0. 05). The levels of 8-OHdG, high-sensitive c-reactive protein (hs-CRP) and brain natriuretic peptide (BNP) after treatment re- duced in 40 mg/d atorvastatin treatment group (P〈0. 05). Intra-group comparison showed the levels of 8-OHdG, hs- CRP and BNP in 40 mg/d treatment group were significantly less than these in 20 mg/d treatment group after treatment (P(0. 05). Conclusion Differents doses of atorvastatin do exist differences in antioxidation. Levels of 8-OHdG in 40 mg/d atorvastatin treatment group are obviously lower than these in 20 mg/d atorvastatin treatment group.

关 键 词: 阿托伐他汀 缺血性心肌病 羟基脱氧鸟嘌呤 氧化应激

相关作者

作者 宋博雅
作者 宋德军
作者 房凯
作者 侯改霞

相关机构对象

机构 华南师范大学
机构 华南师范大学体育科学学院
机构 广州体育学院
机构 西安体育学院
机构 首都医科大学附属北京康复医院

相关领域作者

作者 庞菊香
作者 康秋实
作者 康超
作者 廖伟导
作者 廖刚